Acrocyanosis due to imipramine
- PMID: 3348672
- PMCID: PMC1778745
- DOI: 10.1136/adc.63.2.204
Acrocyanosis due to imipramine
Abstract
An 11 year old girl who was being treated for enuresis with imipramine developed acrocyanosis of the hands and feet. All biochemical and haematological investigations gave normal results. When imipramine was stopped the girl recovered within three days.
Similar articles
-
Acrocyanosis as a side effect of tricyclic antidepressants: a case report.Turk J Pediatr. 2003 Apr-Jun;45(2):155-7. Turk J Pediatr. 2003. PMID: 12921305
-
The adverse influence of imipramine on the adaptation of the newborn infant to extrauterine life.Acta Paediatr Belg. 1972;26(4):197-204. Acta Paediatr Belg. 1972. PMID: 4656174 No abstract available.
-
Diagnosis of phaeochromocytoma after ingestion of imipramine.Arch Dis Child. 1978 Aug;53(8):676-7. doi: 10.1136/adc.53.8.676. Arch Dis Child. 1978. PMID: 708107 Free PMC article.
-
Imipramine-induced hyperpigmentation: a case report and review of the literature.J Cutan Pathol. 2009 Jul;36(7):799-803. doi: 10.1111/j.1600-0560.2008.01121.x. J Cutan Pathol. 2009. PMID: 19519613 Review.
-
[Drug therapy of enuresis].Z Kinder Jugendpsychiatr Psychother. 1996 Mar;24(1):18-33. Z Kinder Jugendpsychiatr Psychother. 1996. PMID: 9459680 Review. German. No abstract available.
Cited by
-
Acrocyanosis: the Flying Dutchman.Vasc Med. 2011 Aug;16(4):288-301. doi: 10.1177/1358863X11398519. Epub 2011 Mar 22. Vasc Med. 2011. PMID: 21427140 Free PMC article. Review.
-
Drug therapy for nocturnal enuresis. Current treatment recommendations.Drugs. 1992 Jul;44(1):47-56. doi: 10.2165/00003495-199244010-00004. Drugs. 1992. PMID: 1379909 Review.
-
Acrocyanosis: an overview.Indian J Dermatol. 2013 Nov;58(6):417-20. doi: 10.4103/0019-5154.119946. Indian J Dermatol. 2013. PMID: 24249890 Free PMC article.
-
Nocturnal enuresis.Pediatr Nephrol. 1995 Feb;9(1):94-103. Pediatr Nephrol. 1995. Corrected and republished in: Pediatr Nephrol. 1995 Jun;9(3):94-103. PMID: 7742233 Corrected and republished. Review.
-
Signal that reboxetine use is linked with symptoms of peripheral ischaemia (Raynaud's syndrome).Eur J Clin Pharmacol. 2003 Jul;59(3):261-2. doi: 10.1007/s00228-003-0611-5. Epub 2003 May 17. Eur J Clin Pharmacol. 2003. PMID: 12756515 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources